Stocks · Health care · Pharmaceutical Preparations

Xencor Inc

XNCR Clue Score24

United States Fiscal year ends December CIK 0001326732 Results filed 4 Nov 2026

Add to watchlist

What the insiders did Net selling

By person

13 insiders · 21 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Bassil I Dahiyat

President & CEO

—

$2.12M (4) scheduled

−$2.12M

546,316

0.7348%

$7.13M

+54.2%

John R Desjarlais

Sr. Vice President & CSO

—

$1.26M (4) scheduled

−$1.26M

263,831

0.3548%

$3.45M

+31.8%

Kevin Charles Gorman

Director

—

$92.66K (1) scheduled

−$92.66K

21,680

0.0292%

$283.14K

+158.3%

Ellen Feigal

Director

—

$89.37K (1) scheduled

−$89.37K

12,340

0.0166%

$161.16K

—

Celia Eckert

SVP, General Counsel

—

$73.70K (3)

−$73.70K

76,918

0.1034%

$1.00M

+58.5%

Bart Jan Cornelissen

Sr. Vice President & CFO

—

$71.30K (2)

−$71.30K

75,898

0.1021%

$991.23K

+71.5%

Kurt A Gustafson

Director

—

$67.38K (1) scheduled

−$67.38K

25,011

0.0336%

$326.64K

+163.6%

Richard J Ranieri

Director

—

$67.38K (1) scheduled

−$67.38K

24,011

0.0323%

$313.58K

+182.8%

Alan Bruce Montgomery

Director

—

$62.34K (1) scheduled

−$62.34K

25,849

0.0348%

$337.59K

+182.8%

Nancy Valente

EVP, Chief Development Officer

—

—

—

49,169

0.0661%

$642.15K

−12.7%

Barbara Klencke

Director

—

—

—

29,974

0.0403%

$391.46K

+400.7%

Todd E Simpson

Director

—

—

—

23,988

0.0323%

$313.28K

—

Raymond Joseph Deshaies

Director

—

—

—

10,302

0.0139%

$134.54K

—